Two risk factors for hypozincemia in diabetic β-thalassemia patients: Hepatitis C and deferasirox.

Two risk factors for hypozincemia in diabetic β-thalassemia patients: Hepatitis C and deferasirox.

<h4>Background and aim</h4>Hypozincemia is a prevalent adverse consequence in diabetes mellitus (DM) and β-Thalassemia patients. We aimed to evaluate the level of serum zinc in β-thalassemia patients with DM and a risk assessment for hypozincemia.<h4>Methods</h4>The study pop...

ver descrição completa

Detalhes bibliográficos
Principais autores: Hadi Darvishi-Khezri, Hossein Karami, Mohammad Naderisorki, Mobin Ghazaiean, Mehrnoush Kosaryan, Amir Mosanejad-Galchali, Aily Aliasgharian, Hasan Karami
Formato: Artigo
Idioma:English
Publicado em: Public Library of Science (PLoS) 2024-01-01
coleção:PLoS ONE
Acesso em linha:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0284267&type=printable

Internet

https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0284267&type=printable

Registros relacionados